Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 334
Immune Disorders Drugs 206
Biopharmaceuticals 175
Musculoskeletal Disorders Drugs 125
Genomics 115
Cardiovascular Drugs 104
Biotechnology 84
Pharmaceuticals 81
Drug Discovery 77
Endocrine and Metabolic Disorders Drugs 76
Biosimilars and Biosuperiors 72
Allergy and Immunology 67
Infusions and Injectables 64
Leukemia Drugs 63
Hematological Drugs 60
Oncology 52
Clinical Trials 51
Dermatological Drugs 51
Central Nervous System Drugs 49
Liver and Kidney Disorders Drugs 45
Women's Health 44
Needles and Syringes 41
Drug Delivery 38
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 30
Infectious Diseases Drugs 28
Brain Cancer Drugs 28
Enzymes 27
Lung Cancer Drugs 26
Colon Cancer Drugs 26
Proteomics 26
Gastrointestinal Drugs 26
Analgesics 24
Immunosuppressive Drugs 24
Lymphoma Drugs 23
Pharmaceutical Manufacturing 19
Drugs by Therapeutic Area 18
Dermatology 18
Optical 17
Therapeutic Area 16
Respiratory Drugs 16
Urology and Nephrology 15
Healthcare Services 14
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Prostate Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Cardiology 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Pulmonary Medicine 7
In Vitro Diagnostics 7
Biomarkers 7
Anti-Obesity Drugs 7
Gastroenterology 7
Neurology 6
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Company Reports 5
Animal Pharmaceuticals 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Pharmaceutical Intermediates 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

2,078 Results (Page 10 of 104)
- Relevance
  Sort by

mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035, by Application Area, Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions

 Report
January 2025
343 Pages
Global

From

€4274EUR$4,799USD£3,727GBP

Metastatic Renal Cell Carcinoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
170 Pages
Global

From

€2226EUR$2,500USD£1,941GBP

Lung Cancer Therapeutics Market 2025-2029

 Report
February 2025
216 Pages
Global

From

€2226EUR$2,500USD£1,941GBP

US Kidney Cancer Therapeutics and Diagnostics Market to 2028

 Report
October 2023
85 Pages
United States

From

€4319EUR$4,850USD£3,766GBP

TIL Therapies Market Industry Trends and Global Forecasts to 2035, by Target Indication, Key Players and Key Geographical Regions

 Report
February 2025
315 Pages
Global

From

€4274EUR$4,799USD£3,727GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Progressive Multifocal Leukoencephalopathy Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3998EUR$4,490USD£3,487GBP

Skin Cancer Diagnostics and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
110 Pages
Global

From

€4230EUR$4,750USD£3,689GBP

Pediatric Drugs and Vaccines - Global Strategic Business Report

 Report
May 2026
292 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Skin Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
120 Pages
Global

From

€4230EUR$4,750USD£3,689GBP

Skin Cancer Drugs Market - Global Strategic Business Report

 Report
May 2026
483 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Psoriasis Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
196 Pages
Global

From

€3157EUR$3,545USD£2,753GBP

€3508EUR$3,939USD£3,059GBP

Global Markets for Bioengineered Protein Drugs

 Report
March 2023
185 Pages
Global

From

€2226EUR$2,500USD£1,941GBP

Biologic Medications for Psoriasis Market - Global Forecast 2025-2030

 Report
August 2025
188 Pages
Global

From

€3157EUR$3,545USD£2,753GBP

€3508EUR$3,939USD£3,059GBP

Anaplastic Thyroid Cancer Drugs Market - Global Strategic Business Report

 Report
May 2026
142 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Chronic Kidney Disease Treatment Market - Global Strategic Business Report

 Report
May 2026
281 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Bipolar Disorder Treatment Market - Global Strategic Business Report

 Report
May 2026
387 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Non-opioid Pain Treatment - Global Strategic Business Report

 Report
May 2026
480 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Hairy Cell Leukemia Therapeutics Market 2024-2028

 Report
July 2024
146 Pages
Global

From

€2226EUR$2,500USD£1,941GBP

Multiple Myeloma Drugs Market 2024-2028

 Report
July 2024
179 Pages
Global

From

€2226EUR$2,500USD£1,941GBP

Nivolumab Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3998EUR$4,490USD£3,487GBP

2,078 Results (Page 10 of 104)
- 1
- 8
- 9
- 10
- 11
- 12

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.